COMMUNIQUÉS West-GlobeNewswire

-
New Opportunity Navigator™ Predictive Analytics Solution Refined Through Vital Images® and Fairview Collaboration
05/03/2018 -
Biodesix Raises Add-On to Series G, Enters into Debt Refinancing Agreement with Innovatus Capital Partners
05/03/2018 -
Notification about capital shares
05/03/2018 -
GW Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference on 12 March
05/03/2018 -
Healthwise and Mytonomy Partner to Deliver Health Education Videos
05/03/2018 -
Adaptimmune to Report Fourth Quarter / Full Year 2017 Financial Results and Business Update on Thursday March 15, 2018
05/03/2018 -
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of February 28, 2018
05/03/2018 -
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 28 février 2018
05/03/2018 -
VALNEVA : Déclaration d'actions et de droits de vote - février 2018
05/03/2018 -
Shire plc : Director/PDMR Shareholding
05/03/2018 -
Asthma Adherence Management Findings Utilizing Adherium’s Smartinhaler™ Technology Presented at AAAAI/WAO
05/03/2018 -
Ossur Hf : Össur hf. initiates a new share buyback program
05/03/2018 -
Ossur Hf : Share buyback program completed
05/03/2018 -
Shire plc : U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
05/03/2018 -
The Alliance for Regenerative Medicine Releases 2017 Annual Data Report, Highlighting Sector Trends and Metrics
05/03/2018 -
Tetra Bio-Pharma Announces Closing of Bought Deal Financing
05/03/2018 -
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
05/03/2018 -
Celsion Announces Ovarian Cancer Expert Presentation at Oppenheimer & Co. Investor Event
05/03/2018 -
Transactions under Novozymes’ stock buyback program
05/03/2018
Pages